Home » Shop » Prescription Treatments » Sexual Health » HIV Prevention » Emtricitabine/Tenofovir (Generic Truvada) PrEP Treatment – 30 Tablets
Buy Emtricitabine/Tenofovir (Generic Truvada) PrEP Treatment Online

Emtricitabine/Tenofovir (Generic Truvada) PrEP Treatment – 30 Tablets

£65.99

  • Active Ingredients: Emtricitabine & Tenofovir
  • Helps prevent and treat HIV
  • 92-99% effective when taken correctly

Both of these active substances are antiretroviral medicines which are used to treat HIV infection. Emtricitabine is a nucleoside reverse transcriptase inhibitor and tenofovir is a nucleotide reverse transcriptase inhibitor.

In stock

  • Total

SKU: 5016695007762-2 Category: Tag:
Trustpilot

Discreet Packaging

UK Based

  • What Emtricitabine/Tenofovir disoproxil Mylan is and what it is used for

    Emtricitabine/Tenofovir disoproxil Mylan contains two active substances, emtricitabine and tenofovir disoproxil. Both of these active substances are antiretroviral medicines which are used to treat HIV infection. Emtricitabine is a nucleoside reverse transcriptase inhibitor and tenofovir is a nucleotide reverse transcriptase inhibitor. However, both are generally known as NRTIs and they work by interfering with the normal working of an enzyme (reverse transcriptase) that is essential for the virus to reproduce itself.
    • Emtricitabine/Tenofovir disoproxil Mylan is used to treat Human Immunodeficiency Virus 1 (HIV-1) infection in adults.
    • It is also used to treat HIV in adolescents aged 12 to less than 18 years who weigh at least 35 kg, and who have already been treated with other HIV medicines that are no longer effective or have caused side effects.
      • - Emtricitabine/Tenofovir disoproxil Mylan should always be used combined with other medicines to treat HIV infection.
      • - Emtricitabine/Tenofovir disoproxil Mylan can be administered in place of emtricitabine and tenofovir disoproxil used separately at the same doses.
    People who are HIV positive can still pass on HIV when taking this medicine, although the risk is lowered by effective antiretroviral therapy. Discuss with your doctor the precautions needed to avoid infecting other people. This medicine is not a cure for HIV infection. While taking Emtricitabine/Tenofovir disoproxil Mylan you may still develop infections or other illnesses associated with HIV infection. Emtricitabine/Tenofovir disoproxil Mylan is also used to reduce the risk of getting HIV-1 infection in adults, and adolescents aged 12 years to less than 18 years who weigh at least 35 kg, when used as a daily treatment, together with safer sex practices: See section 2 for a list of precautions to take against HIV infection.

  • Side effects

    Like all medicines, this medicine can cause side effects, although not everybody gets them.

    Possible serious side effects:

    • Lactic acidosis (excess lactic acid in the blood) is a rare but potentially life-threatening side effect. Lactic acidosis occurs more often in women, particularly if they are overweight, and in people with liver disease. The following may be signs of lactic acidosis:
      • deep rapid breathing
      • drowsiness
      • feeling sick (nausea), being sick (vomiting)
      • stomach pain

    If you think you may have lactic acidosis, get medical help immediately.

    • Any signs of inflammation or infection. In some patients with advanced HIV infection (AIDS) and a history of opportunistic infections (infections that occur in people with a weak immune system), signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. It is thought that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
    • Autoimmune disorders, when the immune system attacks healthy body tissue, may also occur after you start taking medicines to treat HIV infection. Autoimmune disorders may occur many months after the start of treatment. Look out for any symptoms of infection or other symptoms such as:
      • muscle weakness
      • weakness beginning in the hands and feet and moving up towards the trunk of the body – palpitations, tremor or hyperactivity

    If you notice these or any symptoms of inflammation or infection, get medical help immediately.

    Please read the patient information leaflet for a full list of other side effects that can occur.

  • Ingredients

    • The active substances are emtricitabine and tenofovir. Each Emtricitabine/Tenofovir disoproxil film-coated tablet contains 200mg of emtricitabine and 245mg of tenofovir disoproxil (equivalent to 300.6 mg of tenofovir disoproxil succinate).
    • The other ingredients are lactose monohydrate, microcrystalline cellulose (E460), starch pregelatinised maize, croscarmellose sodium, magnesium stearate (E470b), poly(vinyl alcohol)(E1203), titanium dioxide (E171), macrogol 3350 (E1521), talc (E553B), indigo carmine aluminium lake (E132).

  • Patient Information Leaflet

    Click here to view the patient information leaflet.

Trustpilot